{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:17:03Z","timestamp":1787066223951,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11908-011-0193-9","type":"journal-article","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T00:41:36Z","timestamp":1304469696000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["West Nile Virus Neuroinvasive Disease"],"prefix":"10.1007","volume":"13","author":[{"given":"Roberta L.","family":"DeBiasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"193_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"D Nash","year":"2001","unstructured":"Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807\u201314.","journal-title":"N Engl J Med."},{"key":"193_CR2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11:1167\u201373.","journal-title":"Emerg Infect Dis."},{"issue":"2","key":"193_CR3","first-page":"1","volume":"59","author":"NP Lindsey","year":"2010","unstructured":"\u2022\u2022 Lindsey NP, Staples JE, Lehman JA, Fischer M. Surveillance for human West Nile virus disease - United States, 1999\u20132008. MMWR Surveill Summ. 2010;59(2):1\u201317. This is the most up-to-date summary on incidence rates for WNND over the 10-year period of WNV circulation in North America following first emergence, including incidence rates by age groups and top states for reported cases. The discussion of stability in incidence rates between 2004 and 2007 is suggestive of a potential endemic level of WNV transmission.","journal-title":"MMWR Surveill Summ."},{"issue":"25","key":"193_CR4","first-page":"769","volume":"59","author":"Centers for Disease Control (CDC)","year":"2010","unstructured":"\u2022 Centers for Disease Control (CDC). West Nile virus activity - United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(25):769\u201372. This is the most up-to-date single-year summary of WNV activity (including WNND), including the lowest incidence rate since the appearance of WNV in North America.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"193_CR5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.2008.79.974","volume":"79","author":"CA Reimann","year":"2008","unstructured":"Reimann CA, Hayes EB, DiGuiseppi C, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999\u20132007. Am J Trop Med Hyg. 2008;79:974\u20139.","journal-title":"Am J Trop Med Hyg."},{"key":"193_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1128\/CVI.13.3.314-318.2006","volume":"13","author":"BK Schweitzer","year":"2006","unstructured":"Schweitzer BK, Kramer WL, Sambol AR, et al. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314\u20138.","journal-title":"Clin Vaccine Immunol."},{"key":"193_CR7","first-page":"281","volume":"53","author":"Centers for Disease Control (CDC)","year":"2004","unstructured":"Centers for Disease Control (CDC). West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:281\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"193_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMe058144","volume":"353","author":"LR Petersen","year":"2005","unstructured":"Petersen LR, Epstein JS. Problem solved? West Nile virus and transfusion safety. N Engl J Med. 2005;353:516\u20137.","journal-title":"N Engl J Med."},{"key":"193_CR9","unstructured":"Centers for Disease Control (CDC). West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:1263\u20137."},{"key":"193_CR10","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1542\/peds.2005-2024","volume":"117","author":"DR O\u2019Leary","year":"2006","unstructured":"O\u2019Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile virus infection of pregnant women in the United States: 2003\u20132004. Pediatrics. 2006;117:e537\u201345.","journal-title":"Pediatrics."},{"key":"193_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-141-5-200409070-00010","volume":"141","author":"JT Watson","year":"2004","unstructured":"Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004;141:360\u20135.","journal-title":"Ann Intern Med."},{"key":"193_CR12","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archneur.61.8.1190","volume":"61","author":"KL Tyler","year":"2004","unstructured":"Tyler KL. West Nile virus infection in the United States. Arch Neurol. 2004;61:1190\u20135.","journal-title":"Arch Neurol."},{"key":"193_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/rmv.501","volume":"16","author":"JJ Sejvar","year":"2006","unstructured":"Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16:209\u201324.","journal-title":"Rev Med Virol."},{"key":"193_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","volume":"57","author":"EB Hayes","year":"2006","unstructured":"Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med. 2006;57:181\u201394.","journal-title":"Annu Rev Med."},{"key":"193_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/01.inf.0000243324.14658.58","volume":"25","author":"EB Hayes","year":"2006","unstructured":"Hayes EB. West Nile virus disease in children. Pediatr Infect Dis J. 2006;25:1065\u20136.","journal-title":"Pediatr Infect Dis J."},{"key":"193_CR16","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1542\/peds.2008-3278","volume":"123","author":"NP Lindsey","year":"2009","unstructured":"\u2022\u2022 Lindsey NP, Hayes EB, Staples JE, Fischer M. West Nile virus disease in children, United States, 1999\u20132007. Pediatrics. 2009;123:e1084-9. This is the most comprehensive summary of pediatric cases of WNV in the United States over the 9\u00a0years following the first US appearance of WNV.","journal-title":"Pediatrics."},{"key":"193_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/01.icu.0000143687.45232.f1","volume":"15","author":"SJ Bakri","year":"2004","unstructured":"Bakri SJ, Kaiser PK. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol. 2004;15:537\u201340.","journal-title":"Curr Opin Ophthalmol."},{"key":"193_CR18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3201\/eid1107.040991","volume":"11","author":"JJ Sejvar","year":"2005","unstructured":"Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11:1021\u20137.","journal-title":"Emerg Infect Dis."},{"key":"193_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.20959","volume":"60","author":"LE Davis","year":"2006","unstructured":"Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol. 2006;60:286\u2013300.","journal-title":"Ann Neurol."},{"key":"193_CR20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174\u20139.","journal-title":"Emerg Infect Dis."},{"key":"193_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/vbz.2007.0137","volume":"8","author":"NP Lindsey","year":"2008","unstructured":"Lindsey NP, Kuhn S, Campbell GL, Hayes EB. West Nile virus neuroinvasive disease incidence in the United States, 2002\u20132006. Vector Borne Zoonotic Dis. 2008;8:35\u20139.","journal-title":"Vector Borne Zoonotic Dis."},{"key":"193_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3201\/eid1405.071066","volume":"14","author":"KA Caillouet","year":"2008","unstructured":"Caillouet KA, Michaels SR, Xiong X, et al. Increase in West Nile neuroinvasive disease after Hurricane Katrina. Emerg Infect Dis. 2008;14:804\u20137.","journal-title":"Emerg Infect Dis."},{"key":"193_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1542\/peds.113.5.1375","volume":"113","author":"EB Hayes","year":"2004","unstructured":"Hayes EB, O\u2019Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics. 2004;113:1375\u201381.","journal-title":"Pediatrics."},{"key":"193_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.TP.0000101434.98873.CB","volume":"77","author":"D DeSalvo","year":"2004","unstructured":"DeSalvo D, Roy-Chaudhury P, Peddi R, et al. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation. 2004;77:466\u20139.","journal-title":"Transplantation."},{"key":"193_CR25","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archneur.61.8.1210","volume":"61","author":"BK Kleinschmidt-DeMasters","year":"2004","unstructured":"Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol. 2004;61:1210\u201320.","journal-title":"Arch Neurol."},{"key":"193_CR26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1017\/S0950268806006339","volume":"134","author":"K Murray","year":"2006","unstructured":"Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect. 2006;134:1325\u201332.","journal-title":"Epidemiol Infect."},{"issue":"2","key":"193_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1399-0012.2009.01044.x","volume":"24","author":"ME Levi","year":"2010","unstructured":"Levi ME, Quan D, Ho JT, et al. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant. 2010;24(2):223\u20138.","journal-title":"Clin Transplant."},{"key":"193_CR28","unstructured":"\u2022 Murray KO, Koers E, Baraniuk S, et al. Risk Factors for Encephalitis from West Nile Virus: a matched case-control study using hospitalized controls. Zoonoses Public Health 2009 Jan 17 (Epub ahead of print). This is a recent nested case-control study to determine potential risk factors for developing WNE by analysis of WNV cases hospitalized in Houston from 2002 to 2004."},{"key":"193_CR29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3201\/eid0903.020531","volume":"9","author":"JT Roehrig","year":"2003","unstructured":"Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376\u20139.","journal-title":"Emerg Infect Dis."},{"key":"193_CR30","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/JCM.43.12.5873-5875.2005","volume":"43","author":"PN Levett","year":"2005","unstructured":"Levett PN, Sonnenberg K, Sidaway F, et al. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol. 2005;43:5873\u20135.","journal-title":"J Clin Microbiol."},{"key":"193_CR31","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1128\/JCM.39.12.4506-4513.2001","volume":"39","author":"RS Lanciotti","year":"2001","unstructured":"Lanciotti RS, Kerst AJ. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol. 2001;39:4506\u201313.","journal-title":"J Clin Microbiol."},{"key":"193_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/01.wnl.0000195890.70898.1f","volume":"66","author":"KL Tyler","year":"2006","unstructured":"Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66:361\u20135.","journal-title":"Neurology."},{"key":"193_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mus.21448","volume":"41","author":"A Petzold","year":"2010","unstructured":"Petzold A, Groves M, Leis AA, et al. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection. Muscle Nerve. 2010;41:42\u20139.","journal-title":"Muscle Nerve."},{"key":"193_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2004.01.013","volume":"220","author":"R Brilla","year":"2004","unstructured":"Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci. 2004;220:37\u201340.","journal-title":"J Neurol Sci."},{"key":"193_CR35","first-page":"289","volume":"26","author":"M Ali","year":"2005","unstructured":"Ali M, Safriel Y, Sohi J, et al. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005;26:289\u201397.","journal-title":"AJNR Am J Neuroradiol."},{"key":"193_CR36","first-page":"1986","volume":"26","author":"KA Petropoulou","year":"2005","unstructured":"Petropoulou KA, Gordon SM, Prayson RA, Ruggierri PM. West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol. 2005;26:1986\u201395.","journal-title":"AJNR Am J Neuroradiol."},{"key":"193_CR37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/NEN.0b013e3181b88114","volume":"68","author":"KA Gyure","year":"2009","unstructured":"Gyure KA. West Nile virus infections. J Neuropathol Exp Neurol. 2009;68:1053\u201360.","journal-title":"J Neuropathol Exp Neurol."},{"key":"193_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/NEN.0b013e3181b8ba14","volume":"68","author":"PK Blakely","year":"2009","unstructured":"Blakely PK, Kleinschmidt-DeMasters BK, Tyler KL, Irani DN. Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol. 2009;68:1061\u201372.","journal-title":"J Neuropathol Exp Neurol."},{"key":"193_CR39","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1086\/518281","volume":"44","author":"JJ Sejvar","year":"2007","unstructured":"Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis. 2007;44:1617\u201324.","journal-title":"Clin Infect Dis."},{"key":"193_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/vbz.2007.0109","volume":"8","author":"KO Murray","year":"2008","unstructured":"Murray KO, Baraniuk S, Resnick M, et al. Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002\u20132004. Vector Borne Zoonotic Dis. 2008;8:167\u201374.","journal-title":"Vector Borne Zoonotic Dis."},{"key":"193_CR41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3201\/eid1203.050643","volume":"12","author":"JJ Sejvar","year":"2006","unstructured":"Sejvar JJ, Bode AV, Marfin AA, et al. West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis. 2006;12:514\u20136.","journal-title":"Emerg Infect Dis."},{"key":"193_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1348\/174866407X218312","volume":"2","author":"JJ Sejvar","year":"2008","unstructured":"Sejvar JJ, Curns AT, Welburg L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol. 2008;2:477\u201399.","journal-title":"J Neuropsychol."},{"key":"193_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3201\/eid1303.060602","volume":"13","author":"KO Murray","year":"2007","unstructured":"Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerg Infect Dis. 2007;13:479\u201381.","journal-title":"Emerg Infect Dis."},{"key":"193_CR44","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1208.060097","volume":"12","author":"KY Haaland","year":"2006","unstructured":"Haaland KY, Sadek J, Pergam S, et al. Mental status after West Nile virus infection. Emerg Infect Dis. 2006;12:1260\u20132.","journal-title":"Emerg Infect Dis."},{"key":"193_CR45","doi-asserted-by":"crossref","unstructured":"Sadek JR, Pergam SA, Harrington JA, et al. Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol. 2009 Jun 8:1\u20138 (Epub ahead of print).","DOI":"10.1080\/13803390902881918"},{"key":"193_CR46","doi-asserted-by":"publisher","first-page":"e1000452","DOI":"10.1371\/journal.ppat.1000452","volume":"5","author":"MS Diamond","year":"2009","unstructured":"\u2022\u2022 Diamond MS. Virus and host determinants of West Nile virus pathogenesis. PLoS Pathog. 2009;5:e1000452. This is an up-to-date, concise review of current science providing insights into WNV and WNND pathogenesis, including host genetic factors and viral determinants.","journal-title":"PLoS Pathog."},{"key":"193_CR47","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ng2097","volume":"39","author":"AC Brault","year":"2007","unstructured":"Brault AC, Huang CY, Langevin SA, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet. 2007;39:1162\u20136.","journal-title":"Nat Genet."},{"key":"193_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.virol.2009.01.038","volume":"387","author":"RM Moudy","year":"2009","unstructured":"Moudy RM, Zhang B, Shi PY, Kramer LD. West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology. 2009;387:222\u20138.","journal-title":"Virology."},{"key":"193_CR49","first-page":"35","volume":"18","author":"DW Beasley","year":"2004","unstructured":"Beasley DW, Davis CT, Whiteman M, et al. Molecular determinants of virulence of West Nile virus in North America. Arch Virol Suppl. 2004;18:35\u201341.","journal-title":"Arch Virol Suppl."},{"key":"193_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.virol.2006.03.007","volume":"349","author":"JA Wicker","year":"2006","unstructured":"Wicker JA, Whiteman MC, Beasley DW, et al. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology. 2006;349:245\u201353.","journal-title":"Virology."},{"key":"193_CR51","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1128\/JVI.01122-06","volume":"80","author":"MA Samuel","year":"2006","unstructured":"Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80:9349\u201360.","journal-title":"J Virol."},{"key":"193_CR52","doi-asserted-by":"publisher","first-page":"e15343","DOI":"10.1371\/journal.pone.0015343","volume":"5","author":"P Piazza","year":"2010","unstructured":"Piazza P, McMurtrey CP, Lelic A, et al. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS ONE. 2010;5:e15343.","journal-title":"PLoS ONE."},{"key":"193_CR53","first-page":"3266","volume":"119","author":"MC Lanteri","year":"2009","unstructured":"Lanteri MC, O\u2019Brien KM, Purtha WE, et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest. 2009;119:3266\u201377.","journal-title":"J Clin Invest."},{"key":"193_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/vbz.2009.0259","volume":"10","author":"KL Mansfield","year":"2010","unstructured":"Mansfield KL, Johnson N, Cosby SL, et al. Transcriptional upregulation of SOCS 1 and suppressors of cytokine signaling 3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA after infection with West Nile virus or tick-borne encephalitis virus. Vector Borne Zoonotic Dis. 2010;10:649\u201353.","journal-title":"Vector Borne Zoonotic Dis."},{"key":"193_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1742-2094-7-73","volume":"7","author":"M Kumar","year":"2010","unstructured":"Kumar M, Verma S, Nerurkar VR. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J Neuroinflammation. 2010;7:73.","journal-title":"J Neuroinflammation."},{"key":"193_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20051970","volume":"203","author":"WG Glass","year":"2006","unstructured":"Glass WG, McDermott DH, Lim JK, et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med. 2006;203:35\u201340.","journal-title":"J Exp Med."},{"key":"193_CR57","doi-asserted-by":"publisher","first-page":"e1000321","DOI":"10.1371\/journal.ppat.1000321","volume":"5","author":"JK Lim","year":"2009","unstructured":"Lim JK, Lisco A, McDermott DH, et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5:e1000321.","journal-title":"PLoS Pathog."},{"key":"193_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.antiviral.2009.05.006","volume":"83","author":"MS Diamond","year":"2009","unstructured":"\u2022\u2022 Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res. 2009;83:214\u201327. This excellent, up-to-date review describes the current state of knowledge on epidemiology, clinical presentation, pathogenesis, and immunobiology of WNV infection, with particular focus on progress toward development of effective therapies.","journal-title":"Antiviral Res."},{"key":"193_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3201\/eid0704.010414","volume":"7","author":"MY Chowers","year":"2001","unstructured":"Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675\u20138.","journal-title":"Emerg Infect Dis."},{"key":"193_CR60","doi-asserted-by":"publisher","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","volume":"79","author":"MA Samuel","year":"2005","unstructured":"Samuel MA, Diamond MS. Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79:13350\u201361.","journal-title":"J Virol."},{"key":"193_CR61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/095632020401500202","volume":"15","author":"JD Morrey","year":"2004","unstructured":"Morrey JD, Day CW, Julander JG, et al. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother. 2004;15:101\u20139.","journal-title":"Antivir Chem Chemother."},{"key":"193_CR62","unstructured":"Rahal JJ, Wehbeh WA. Double-blinded, placebo controlled trial of alpha interferon for West Nile virus meningoencephalitis Protocol WIN-102, revised 7\/26\/2004. Available at http:\/\/www.nyhq.org\/posting\/rahal.html. Accessed March 28, 2011."},{"key":"193_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1086\/376870","volume":"188","author":"D Ben Nathan","year":"2003","unstructured":"Ben Nathan D, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis. 2003;188:5\u201312.","journal-title":"J Infect Dis."},{"key":"193_CR64","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","volume":"77","author":"MJ Engle","year":"2003","unstructured":"Engle MJ, Diamond MS. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol. 2003;77:12941\u20139.","journal-title":"J Virol."},{"key":"193_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/13550280801958930","volume":"14","author":"JD Morrey","year":"2008","unstructured":"Morrey JD, Siddharthan V, Wang H, et al. West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. J Neurovirol. 2008;14:152\u201363.","journal-title":"J Neurovirol."},{"key":"193_CR66","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med. 2005;11:522\u201330.","journal-title":"Nat Med."},{"key":"193_CR67","doi-asserted-by":"publisher","first-page":"e1000453","DOI":"10.1371\/journal.ppat.1000453","volume":"5","author":"BS Thompson","year":"2009","unstructured":"Thompson BS, Moesker B, Smit JM, et al. A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog. 2009;5:e1000453.","journal-title":"PLoS Pathog."},{"key":"193_CR68","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1128\/JVI.00286-09","volume":"83","author":"MR Vogt","year":"2009","unstructured":"Vogt MR, Moesker B, Goudsmit J, et al. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol. 2009;83:6494\u2013507.","journal-title":"J Virol."},{"key":"193_CR69","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/599794","volume":"200","author":"S Zhang","year":"2009","unstructured":"Zhang S, Vogt MR, Oliphant T, et al. Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. J Infect Dis. 2009;200:202\u20135.","journal-title":"J Infect Dis."},{"key":"193_CR70","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.0914503107","volume":"107","author":"H Lai","year":"2010","unstructured":"Lai H, Engle M, Fuchs A, et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proc Natl Acad Sci USA. 2010;107:2419\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"193_CR71","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1128\/JVI.79.8.4599-4609.2005","volume":"79","author":"TS Deas","year":"2005","unstructured":"Deas TS, Binduga-Gajewska I, Tilgner M, et al. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol. 2005;79:4599\u2013609.","journal-title":"J Virol."},{"key":"193_CR72","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1086\/428507","volume":"191","author":"F Bai","year":"2005","unstructured":"Bai F, Wang T, Pal U, et al. Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis. 2005;191:1148\u201354.","journal-title":"J Infect Dis."},{"key":"193_CR73","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/JVI.01840-06","volume":"81","author":"F Bai","year":"2007","unstructured":"Bai F, Town T, Pradhan D, et al. Antiviral peptides targeting the west nile virus envelope protein. J Virol. 2007;81:2047\u201355.","journal-title":"J Virol."},{"key":"193_CR74","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1128\/AAC.01457-08","volume":"53","author":"J Chang","year":"2009","unstructured":"Chang J, Wang L, Ma D, et al. Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses. Antimicrob Agents Chemother. 2009;53:1501\u20138.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-011-0193-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0193-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:12:12Z","timestamp":1744017132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-011-0193-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,5]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1007\/s11908-011-0193-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,5]]},"assertion":[{"value":"5 May 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}